BeStock  
Stocks › Medical Devices › DCTH

Delcath Systems DCTH

US equityMarket cap rank #3701Medical Devices
$15.38 −$0.03 (-0.19%)
Pre-market · Oct 8, 9:10 am ET · After hours $15.38 0.00%
Open$15.27
Prev close$15.41
Day range$15.27 – $15.82
Volume263.1K
Market cap$533.67M
P/E (TTM)1,538.0
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$29.13M+20.6% YoY
Operating profit$2.40M-7.5% YoY
Net profit$2.67M-1.1% YoY
Diluted EPS$0.07+0.0% YoY
Free cash flow$5.21M-24.5% YoY
Operating cash flow$5.71M

Revenue, last 8 quarters

$11.2MSep '24$15.1MDec '24$19.8MMar '25$24.2MJun '25$20.6MSep '25$20.7MDec '25$25.0MMar '26$29.1MJun '26

Net profit, last 8 quarters

$1.9MSep '24$-3.4MDec '24$1.1MMar '25$2.7MJun '25$830.0KSep '25$-1.9MDec '25$-1.1MMar '26$2.7MJun '26

Diluted EPS by quarter

0.06Sep '24-0.11Dec '240.03Mar '250.07Jun '250.02Sep '25-0.05Dec '25-0.03Mar '260.07Jun '26

Free cash flow by quarter

$-3.9MSep '24$-1.2MDec '24$2.1MMar '25$6.9MJun '25$4.3MSep '25$7.7MDec '25$287.0KMar '26$5.2MJun '26

Annual revenue

$1.6MFY20$3.6MFY21$2.7MFY22$2.1MFY23$37.2MFY24$85.2MFY25

Profitability & balance sheet

Gross margin87.1%
Operating margin-1.9%
Net margin0.6%
Return on equity0.5%
Return on assets0.4%
Return on invested capital0.5%
Current ratio9.83
Liabilities / assets11.6%
Cash & investments$95.90M
Total debt$2.27M
Net cash (debt)$93.64M
Free cash flow / sales18.3%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Hepzato Kit$27.16M 93.2%
  • Chemosat$1.97M 6.8%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $29.13M $24.99M $85.23M $20.73M $20.56M
Total Operating Revenue $29.13M $24.99M $85.23M $20.73M $20.56M
Cost of Revenue $2.99M $3.74M $11.80M $3.01M $2.62M
Gross Profit $26.15M $21.26M $73.43M $17.72M $17.94M
Operating Expense $23.75M $22.90M $72.77M $19.90M $18.33M
Selling and Admin Expenses $13.37M $13.07M $43.53M $10.53M $10.34M
Research & Development $10.38M $9.82M $29.25M $9.37M $7.99M
Operating Profit $2.40M -$1.64M $660,000.00 -$2.18M -$388,000.00
Net Non-Operating Interest Income (Expense) $781,000.00 $787,000.00 $2.92M $857,000.00 $796,000.00
Non-Operating Interest Income $781,000.00 $787,000.00 – – –
Other Income (Expense) -$17,000.00 -$58,000.00 -$70,000.00 -$7,000.00 -$33,000.00
Other Non-Operating Income (Expenses) -$17,000.00 -$58,000.00 -$70,000.00 -$7,000.00 -$33,000.00
Pretax Profit $3.16M -$908,000.00 $3.51M -$1.33M $375,000.00
Tax $491,000.00 $162,000.00 $810,000.00 $562,000.00 -$455,000.00
Net Profit $2.67M -$1.07M $2.70M -$1.90M $830,000.00
Profit from Continuing Operations $2.67M -$1.07M $2.70M -$1.90M $830,000.00
Net Income to Parent Company $2.67M -$1.07M $2.70M -$1.90M $830,000.00
Net Income to Common Stockholders $2.67M -$1.07M $2.70M -$1.90M $830,000.00
Basic EPS $0.07 -$0.03 $0.08 -$0.05 $0.02
Diluted EPS $0.07 -$0.03 $0.07 -$0.05 $0.02
Total Other Finance Costs – – -$2.92M -$857,000.00 -$796,000.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $137.02M $124.84M $123.63M $123.63M $124.30M
Total Current Assets $130.54M $120.27M $119.53M $119.53M $120.62M
Cash and Cash Equivalents & Short-Term Investments $95.90M $89.30M $91.04M $91.04M $88.91M
-Cash and Cash Equivalents $47.52M $41.31M $43.45M $43.45M $41.81M
-Short Term Investments $48.38M $47.99M $47.58M $47.58M $47.10M
Receivables $16.92M $15.26M $12.94M $12.94M $15.56M
-Accounts Receivable $15.94M $14.16M $11.74M $11.74M $13.75M
-Accrued Interest Receivable $328,000.00 $581,000.00 $499,000.00 $499,000.00 $709,000.00
-Taxes Receivable $653,000.00 $523,000.00 $696,000.00 $696,000.00 $1.10M
Prepaid Assets $3.76M $3.94M $3.76M $3.76M $3.64M
Inventory $11.71M $9.81M $10.25M $10.25M $10.75M
Other Current Assets $2.24M $1.96M $1.55M $1.55M $1.75M
Total Non-Current Assets $6.48M $4.57M $4.10M $4.10M $3.68M
Net PPE $6.48M $4.57M $4.10M $4.10M $3.68M
-Gross PPE $11.93M $9.91M $9.35M $9.35M $8.85M
-Accumulated Depreciation -$5.45M -$5.34M -$5.25M -$5.25M -$5.17M
Total Liabilities $15.87M $12.13M $12.41M $12.41M $9.45M
Total Current Liabilities $13.28M $10.70M $10.95M $10.95M $8.01M
Payables $4.01M $3.46M $2.66M $2.66M $2.13M
-Accounts Payable $4.01M $3.46M $2.66M $2.66M $2.13M
Current Accrued Expenses $4.76M $4.14M $3.55M $3.55M $2.13M
Short-Term Debt and Capital Lease Obligation $196,000.00 $92,000.00 $101,000.00 $101,000.00 $110,000.00
-Current Capital Lease Obligation $196,000.00 $92,000.00 $101,000.00 $101,000.00 $110,000.00
Total Non-Current Liabilities $2.59M $1.43M $1.46M $1.46M $1.44M
Long Term Debt and Capital Lease Obligation $2.27M $815,000.00 $835,000.00 $835,000.00 $855,000.00
-Long Term Capital Lease Obligation $2.27M $815,000.00 $835,000.00 $835,000.00 $855,000.00
Other Non-Current Liabilities $327,000.00 $615,000.00 $628,000.00 $628,000.00 $582,000.00
Total Equity $121.15M $112.71M $111.22M $111.22M $114.85M
Stockholders' Equity $121.15M $112.71M $111.22M $111.22M $114.85M
Capital Stock $346,000.00 $344,000.00 $347,000.00 $347,000.00 $353,000.00
-Common Stock $346,000.00 $344,000.00 $347,000.00 $347,000.00 $353,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $647.79M $641.71M $639.15M $639.15M $640.57M
Retained Earnings -$527.25M -$529.92M -$528.85M -$528.85M -$526.95M
Gains/Losses Not Affecting Retained Earnings $258,000.00 $571,000.00 $575,000.00 $575,000.00 $875,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $5.71M $857,000.00 $22.52M $8.25M $4.77M
Net cash flow from continuing operations $5.71M $857,000.00 $22.52M $8.25M $4.77M
Net Income from Continuing Operations $2.67M -$1.07M $2.70M -$1.90M $830,000.00
Depreciation & Depletion & Amortization $84,000.00 $131,000.00 $349,000.00 $109,000.00 $146,000.00
Change in Working Capital -$1.81M -$2.71M -$3.07M $5.98M -$1.33M
-Change in Receivables -$1.78M -$2.42M -$854,000.00 $2.01M $2.09M
-Change in Inventory -$1.91M $444,000.00 -$3.32M $493,000.00 -$222,000.00
-Change in Prepaid Assets -$229,000.00 -$423,000.00 -$3.42M $498,000.00 -$828,000.00
-Change in Payables and Accrued Expense $2.51M -$273,000.00 $4.77M $2.97M -$2.34M
-Change in Other Current Liabilities -$398,000.00 -$43,000.00 -$241,000.00 $17,000.00 -$23,000.00
Net cash flow from investing -$504,000.00 -$571,000.00 -$26.59M -$561,000.00 -$466,000.00
Net Cash Flow from Continuing Investing Activities -$504,000.00 -$571,000.00 -$26.59M -$561,000.00 -$466,000.00
Net PPE Purchase and Sale -$503,000.00 -$570,000.00 -$1.55M -$550,000.00 -$459,000.00
Net Investment Purchase and Sale -$1,000.00 -$1,000.00 -$25.04M -$11,000.00 -$7,000.00
Financing Cash Flow $962,000.00 -$2.38M $15.05M -$5.94M $3.10M
Net Cash Flow from Continuing Financing Activities $962,000.00 -$2.38M $15.05M -$5.94M $3.10M
Net Common Stock Issuance $378,000.00 -$3.00M -$5.52M -$5.52M -$238,000.00
Proceeds from Stock Option Exercised $584,000.00 $619,000.00 $20.57M -$425,000.00 $3.34M
Ending Cash Balance $47.52M $41.31M $43.45M $43.45M $41.81M
Net Change in Cash $6.17M -$2.10M $10.97M $1.74M $7.41M
Beginning Cash Balance $41.31M $43.45M $32.41M $41.81M $34.42M
Effect of Exchange Rate Changes $38,000.00 -$46,000.00 $68,000.00 -$102,000.00 -$14,000.00
Free Cash Flow $5.21M $287,000.00 $20.97M $7.70M $4.31M
Net Issuance Payments Of Debt – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on DCTH.

Leave a comment

Scroll to Top